tradingkey.logo
tradingkey.logo
検索

Conmed Corp

CNMD
ウォッチリストに追加
46.300USD
-0.670-1.43%
終値 07-31 16:00ET15分遅れの株価
1.39B時価総額
26.11直近12ヶ月PER

詳細情報 Conmed Corp 企業名

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corpの企業情報

企業コードCNMD
会社名Conmed Corp
上場日Jul 23, 1987
最高経営責任者「CEO」Beyer (Patrick J)
従業員数3900
証券種類Ordinary Share
決算期末Jul 23
本社所在地11311 Concept Boulevard
都市LARGO
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号33773
電話番号17272142974
ウェブサイトhttps://www.conmed.com/
企業コードCNMD
上場日Jul 23, 1987
最高経営責任者「CEO」Beyer (Patrick J)

Conmed Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--

よくある質問

Conmed Corpの上位5名の株主は誰ですか?

Conmed Corpの上位5名の株主は以下のとおりです。Mr. David M. Bronson

Conmed Corp(CNMD)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Conmed Corpの株式を保有している機関は638社あり、保有株式の総市場価値は約34.51Mで、全体の114.61%を占めています。2025Q4と比較して、機関の持ち株は-7041128.00増加しています。

Conmed Corpの最大の収益源は何ですか?

2026Q1において、General Surgery部門がConmed Corpにとって最大の収益を生み出しており、その金額は800.13Mで、全収益の58.20%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。